From First Doseto Final Label
Clinical Pharmacology for Drug Development
Clinical pharmacology connects evidence to a dose, a study, or a label decision. Written for newcomers learning the job and for practitioners opening the chapter that owns their current deliverable.
Malek Okour, PhD
This page is unlisted and shared privately while the book is in draft. Please keep it within your team rather than passing it along.
Evidence → decision
01
Dose
What exposure, for whom
02
Study
The evidence that tests it
03
Label
The decision it supports
Clinical pharmacology connects evidence to a dose, a study, or a label decision.
Blue is what you start from; amber is the work; green is the decision it supports.
Two ways in
Where you should start
For the newcomer
You are learning the job. Start with what clinical pharmacology produces and for whom, then the review that maps the work, then clearance.
For the practitioner
You have a deliverable due. Open the chapter that owns it — a study design, a special population, a report or a meeting package.
Pick a path
Reading shortcuts
V0.3 working draft. 73 chapter texts across 11 parts are drafted; review is ongoing. A written draft is not an accepted or published text.
Have feedback on this draft? Include the book title and edition, the chapter or heading, and the exact passage.
Contact MalekCompanion reports are not included in this web draft.